CEMPACA Trademark

Trademark Overview

On Friday, February 11, 2011, a trademark application was filed for CEMPACA with the United States Patent and Trademark Office. The USPTO has given the CEMPACA trademark a serial number of 85239669. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 15, 2014. This trademark is owned by Glaxo Group Limited. The CEMPACA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
cempaca

General Information

Serial Number85239669
Word MarkCEMPACA
Filing DateFriday, February 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 15, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 15, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 15, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, February 21, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2014EXTENSION 5 GRANTED
Monday, February 3, 2014EXTENSION 5 FILED
Monday, February 3, 2014TEAS EXTENSION RECEIVED
Wednesday, August 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2013EXTENSION 4 GRANTED
Monday, August 5, 2013EXTENSION 4 FILED
Monday, August 5, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2013EXTENSION 3 GRANTED
Friday, January 25, 2013EXTENSION 3 FILED
Friday, January 25, 2013TEAS EXTENSION RECEIVED
Tuesday, August 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 19, 2012EXTENSION 2 GRANTED
Thursday, August 2, 2012EXTENSION 2 FILED
Thursday, August 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 2, 2012TEAS EXTENSION RECEIVED
Wednesday, January 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2012EXTENSION 1 GRANTED
Monday, January 23, 2012EXTENSION 1 FILED
Monday, January 23, 2012TEAS EXTENSION RECEIVED
Tuesday, August 9, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2011PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2011ASSIGNED TO EXAMINER
Wednesday, February 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 15, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

cempaca pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological